Centauri Therapeutics Raises £3M in Funding
Summary
Centauri Therapeutics Ltd, a Sandwich, UK-based biotechnology company focused on the treatment of infectious diseases, raised £3m in funding.Backers included Animatrix Capital LLP, a regional investment fund, and private investors.Dix was formerly co-founder and Chief Executive of Convergence Pharmaceuticals Ltd., acquired by Biogen Idec in 2015 in a deal worth up to $675m.Previously, he was a founder and CEO of PowderMed Ltd, acquired by Pfizer in 2006; and Chairman of Auralis Ltd where he managed a successful US trade sale.Centauri Therapeutics has established and is based at a core R&D facility at Discovery Park in Sandwich, Kent.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected